{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:57:47Z","timestamp":1785826667179,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010325","name":"Universidad Nacional del Nordeste","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biopha.2018.08.087","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T23:04:28Z","timestamp":1535151868000},"page":"1046-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Erythropoietin attenuates LPS-induced microvascular damage in a murine model of septic acute kidney injury"],"prefix":"10.1016","volume":"107","author":[{"given":"Tania Romina","family":"Stoyanoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Santiago","family":"Todaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo Melana","family":"Colavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana M\u00f3nica","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.08.087_bib0005","doi-asserted-by":"crossref","DOI":"10.1186\/s40560-016-0146-3","article-title":"Role of kidney injury in sepsis","author":"Doi","year":"2016","journal-title":"J. Intensive Care"},{"key":"10.1016\/j.biopha.2018.08.087_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-013-2427-6","article-title":"Pathophysiology and management of septic acute kidney injury","author":"Romanovsky","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2015.26","article-title":"Microparticles: Markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI","author":"Souza","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.08.087_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury","author":"Gomez","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.biopha.2018.08.087_bib0025","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000000473","article-title":"The endothelium in sepsis","author":"Ince","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.biopha.2018.08.087_bib0030","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-05-1771","article-title":"Erythropoietin biology in cancer","author":"Hardee","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2018.08.087_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.etp.2011.08.006","article-title":"Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats","author":"Mohamed","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0040","doi-asserted-by":"crossref","DOI":"10.5301\/jn.5000178","article-title":"Recombinant human erythropoietin attenuates renal tubulointerstitial injury in murine adriamycin-induced nephropathy","author":"Nakazawa","year":"2013","journal-title":"J. Nephrol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0045","doi-asserted-by":"crossref","DOI":"10.1159\/000223229","article-title":"Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study","author":"Song","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0050","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2012.27.5.506","article-title":"Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting","author":"Oh","year":"2012","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.biopha.2018.08.087_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2010.25","article-title":"Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)","author":"Endre","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.08.087_bib0060","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-13-132","article-title":"Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study","author":"De Seigneux","year":"2012","journal-title":"BMC Nephrol."},{"issue":"R254","key":"10.1016\/j.biopha.2018.08.087_bib0065","article-title":"Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety","volume":"17","author":"Kim","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2018.08.087_bib0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0526-9","article-title":"Erythropoietin and organ protection: lessons from negative clinical trials","author":"Pearl","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2018.08.087_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2014.01.011","article-title":"Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis","author":"Stoyanoff","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2018.08.087_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2016.05.045","article-title":"Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation","author":"Heitrich","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.08.087_bib0085","article-title":"Cell Stress, Hypoxic Response and Apoptosis in Murine Adriamycin-induced Nephropathy","author":"Stoyanoff","year":"2012","journal-title":"J. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0090","doi-asserted-by":"crossref","DOI":"10.1042\/CS20140714","article-title":"PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis","author":"Park","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2018.08.087_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2015.01.002","article-title":"Sepsis-associated acute kidney injury","author":"Alobaidi","year":"2015","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0100","doi-asserted-by":"crossref","DOI":"10.1159\/000329383","article-title":"A role for oxidative stress","author":"Heyman","year":"2011","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI39421","article-title":"Animal models of sepsis and sepsis-induced kidney injury","author":"Doi","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.08.087_bib0110","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00445.2006","article-title":"The role of ICAM-1 in endotoxin-induced acute renal failure","author":"Wu","year":"2007","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfm216","article-title":"Erythropoietin ameliorates renal dysfunction during endotoxaemia","author":"Mitra","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biopha.2018.08.087_bib0120","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0b013e31819b8371","article-title":"Therapeutic effects of erythropoietin in murine models of endotoxin shock","author":"Aoshiba","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2018.08.087_bib0125","doi-asserted-by":"crossref","DOI":"10.2174\/1874276900903010001","article-title":"Tubular erythropoietin receptor expression mediates erythropoietin-induced renoprotection","author":"De Beuf","year":"2009","journal-title":"Open Hematol. J."},{"key":"10.1016\/j.biopha.2018.08.087_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccm.2016.01.009","article-title":"Endothelial and microcirculatory function and dysfunction in sepsis","author":"Colbert","year":"2016","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.biopha.2018.08.087_bib0135","doi-asserted-by":"crossref","DOI":"10.1080\/1547691X.2016.1183733","article-title":"Determinants of hepcidin levels in sepsis-associated acute kidney injury: impact on pAKT\/PTEN pathways?","author":"Schaalan","year":"2016","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2018.08.087_bib0145","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00099.2008","article-title":"VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury","author":"Leonard","year":"2008","journal-title":"AJP Ren. Physiol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0150","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20060375","article-title":"Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality","author":"Yano","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2018.08.087_bib0155","doi-asserted-by":"crossref","DOI":"10.2174\/157016110790226606","article-title":"Role of vascular endothelial growth factor in kidney disease","author":"Doi","year":"2010","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0160","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2013.286","article-title":"TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis","author":"Xu","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.08.087_bib0165","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00971.2001","article-title":"NF-\u03b1 downregulates vascular endothelial Flk-1 expression in human melanoma xenograft model","author":"Menon","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0170","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-011-9337-1","article-title":"Time-dependent alterations of VEGF and its signaling molecules in acute lung injury in a rat model of sepsis","author":"Jesmin","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2018.08.087_bib0175","doi-asserted-by":"crossref","DOI":"10.1590\/S0100-879X2009001200005","article-title":"Collagen XVIII\/endostatin expression in experimental endotoxemic acute renal failure","author":"Cichy","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.biopha.2018.08.087_bib0180","doi-asserted-by":"crossref","DOI":"10.1111\/j.1523-1755.2005.00264.x","article-title":"Renoprotective effect of erythropoietin (EPO): Possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney","author":"Kang","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.08.087_bib0185","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000260179.43672.fe","article-title":"Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice","author":"Nakano","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.08.087_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2015.01.008","article-title":"The microcirculation of the septic kidney","author":"Zafrani","year":"2015","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.biopha.2018.08.087_bib0195","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-011-2267-4","article-title":"The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats","author":"Legrand","year":"2011","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.biopha.2018.08.087_bib0200","article-title":"Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease","author":"Olson","year":"2012","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.biopha.2018.08.087_bib0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.33549\/physiolres.930749","article-title":"Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes","volume":"55","author":"Genc","year":"2006","journal-title":"Physiol. Res."},{"key":"10.1016\/j.biopha.2018.08.087_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2011.11.013","article-title":"Recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats","author":"Yang","year":"2012","journal-title":"Injury"},{"key":"10.1016\/j.biopha.2018.08.087_bib0215","article-title":"Paeonol protects endotoxin-induced acute kidney injury: potential mechanism of inhibiting TLR4-NF-\u03baB signal pathway","author":"Fan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.08.087_bib0220","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2013.362","article-title":"HIF meets NF-kappa B signaling","author":"Willam","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.08.087_bib0225","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2013.118","article-title":"Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the \u03b2-common receptor","author":"Coldewey","year":"2013","journal-title":"Kidney Int."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218337454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218337454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:29:13Z","timestamp":1766024953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218337454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":45,"alternative-id":["S0753332218337454"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.087","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietin attenuates LPS-induced microvascular damage in a murine model of septic acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}